Clinical Trials in San Francisco

Showing 10741-10760 of 12,991 trials

Intervention for (Those) Recently Informed of Seropositive Status (IRISS)

NCT00720733

An intervention designed to increase positive affect in a population newly diagnosed with HIV will be effective at improving affect and HIV-related outcomes such as mental and physical health, coping and coping resources.

HIV Infections

University of California, San Francisco160 participantsStarted Sep 2008

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

NCT00002849

RATIONALE: Chemotherapy plus interferon alfa may be effective for primary systemic amyloidosis. PURPOSE: Phase II trial to study the effectiveness of dexamethasone plus interferon alfa in treating patients who have primary systemic amyloidosis.

Multiple Myeloma

SWOG Cancer Research Network93 participantsStarted Nov 1996

La Jolla, California, United States • San Francisco, California, United States • Wilmington, Delaware, United States +37 more locations

Intervention for (Those) Recently Informed of Seropositive Status (IRISS)

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Find Trials by Condition in San Francisco

LGBT Internet Based Smoking Treatment - 1

Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)

FLU-FIT Program at Kaiser Permanente Northern California

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.